In March 2025, the company introduced new strategies for a immediate-to-consumer presenting of its Wegovy weight loss drug. The company established a completely new pharmacy, called NovoCare, which would charge clients $499 per 30 days for access to the drug, less than half the price of the drug via other pharmaceutical distribution networks.[53]In